2018
Co-occurring Substance and Mental Health Disorders
Jorandby-Quinones L, Edens E, Rosenheck R. Co-occurring Substance and Mental Health Disorders. 2018, 307-333. DOI: 10.1007/978-1-4939-7438-2_20.ChaptersDual diagnosisMental health care deliveryHigh treatment burdenMore medical conditionsMental health care systemMental health disordersSubstance use disordersCo-occurring substanceEvolution of treatmentHealthcare delivery approachHealth care deliveryHealth care systemTreatment burdenMedical conditionsUse disordersHealth disordersMedical carePatientsCare deliveryPsychosocial conditionsIndividual diseasesCare systemDiagnosisTreatmentDisease
2016
Prevalence and correlates of diabetes mellitus among homeless veterans nationally in the Veterans Health Administration
Iheanacho T, Rosenheck R. Prevalence and correlates of diabetes mellitus among homeless veterans nationally in the Veterans Health Administration. Journal Of Social Distress And The Homeless 2016, 25: 53-59. DOI: 10.1080/10530789.2016.1169722.Peer-Reviewed Original ResearchVeterans Health AdministrationBody mass indexDiabetes mellitusHomeless veteransRisk factorsHealth AdministrationPrevalence of DMChronic medical conditionsRisk of diabetesCurrent epidemiological studiesHomeless adultsPotential risk factorsLogistic regression modelsDM screeningMass indexNon-homeless veteransDiabetes prevalenceClinical assessmentHigh prevalenceMedical conditionsHigh riskEpidemiological studiesMulti-variate analysisPrevalenceSelf-reported data
2006
Special Section on CATIE Baseline Data: Interrelationships of Psychiatric Symptom Severity, Medical Comorbidity, and Functioning in Schizophrenia
Chwastiak L, Rosenheck R, McEvoy J, Keefe R, Swartz M, Lieberman J. Special Section on CATIE Baseline Data: Interrelationships of Psychiatric Symptom Severity, Medical Comorbidity, and Functioning in Schizophrenia. Psychiatric Services 2006, 57: 1102-1109. PMID: 16870960, DOI: 10.1176/ps.2006.57.8.1102.Peer-Reviewed Original ResearchConceptsMedical comorbiditiesMedical conditionsPsychiatric symptom severityPsychosocial functioningNeurocognitive impairmentSchizophrenia symptomsBaseline dataSymptom severityCross-sectional studyPhysical health statusSample of patientsClinical Antipsychotic TrialsPoorer neurocognitive functioningGreater depressive symptomsSevere schizophrenia symptomsSample of personsDiabetes mellitusAntipsychotic pharmacotherapyIndependent associationAntipsychotic TrialsMultivariate regression modelComorbiditiesPsychotic symptomsDepressive symptomsHealth status